# Patient Engagement Advisory Committee; Amendment of Notice
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice; amendment.
**SUMMARY:**
The Food and Drug Administration (FDA) is announcing amendments to the notice of meeting of the Patient Engagement Advisory Committee. This meeting was announced in the *Federal Register* of July 26, 2017. The amendments are being made to reflect time changes in the *DATES* and *Procedure* sections and to add *Webcast Information* to the document. There are no other changes.
**FOR FURTHER INFORMATION CONTACT:**
Letise Williams, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5441, Silver Spring, MD 20993-0002, 301-796-8398; or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code PEAC. Please call the Information Line for up-to-date information on this meeting.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of July 26, 2017 (82 FR 34681), FDA announced that a meeting of the Patient Engagement Advisory Committee would be held on October 11 and 12, 2017. On page 34681, in the third column, the *DATES* section is changed to reflect the time of these meetings on the announced dates.
On page 34682, in the first column, in the *Procedure* section, the third sentence is changed to reflect new times for oral presentations on October 11 and 12.
On page 34682, in the second column, a *Webcast Information* section is added before the last paragraph of the document. The amendments read as follows:
**DATES:**
The meeting will be held on October 11, 2017, from 12:30 p.m. to 6 p.m. and October 12, 2017, from 8 a.m. to 5 p.m.
*Procedure:* Oral presentations from the public will be scheduled between approximately 2:30 p.m. to 3 p.m. on October 11, 2017, and approximately 1 p.m. to 2:30 p.m. on October 12, 2017.
*Webcast Information:* This meeting will also be made available to the public via webcast. The links for the webcasts are below: October 11, 2017: “Patient Engagement Advisory Committee Meeting, Day 1,” *https://event.webcasts.com/starthere.jsp?ei=1157277&tp_key=5580d0c7a5.* October 12, 2017: “Patient Engagement Advisory Committee Meeting, Day 2,” Morning Session— *https://event.webcasts.com/starthere.jsp?ei=1157280&tp_key=dfcde848fe;* and Afternoon Session— *https://event.webcasts.com/starthere.jsp?ei=1157282&tp_key=6d832a247e.*
This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: September 29, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning, Legislation, and Analysis.